Mayukh Sukhatme, President & CIO at Roivant Sciences Ltd. (ROIV), sold 335,174 shares at $37.17 ($12.4M) on 2026-08-19, disclosed to the SEC on 2026-08-21.
Open-market sale of $12.4M ROIV by President & CIO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.17 | 172,899 | $6.4M | 52.0% |
| 2 | $37.30 | 17,519 | $653K | 5.3% |
| 3 | $36.48 | 144,756 | $5.3M | 42.7% |
| Total | $36.88 avg | 335,174 | $12.4M | 100% |
| Filing → |
| ROIV | SELL | 2026-02-11 | $9.0M | — | Filing → |
| ROIV | SELL | 2025-12-31 | $57.8M | — | Filing → |
| ROIV | SELL | 2025-12-19 | $1.2M | — | Filing → |